Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03559075 · ClinicalTrials.gov registry record
Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 480
- Enrollment target
NCT03559075 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 480 participants.
The verdict
NCT03559075 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 480 participants
- Enrollment target
Study Summary
In dermatology, topical anti-inflammatory medications, such as corticosteroids, are the mainstay treatment of managing patients with atopic dermatitis. However, caregivers are often apprehensive about choosing a topical steroid for a variety of reasons. Many caregivers are not aware that clinical trial evidence for these medications exist, and instead may rely on anecdotal evidence in choosing to take these medications. Because fear of the drug is inherently subjective, it can be modified with appropriate reassurance and presentation of evidence. The goal of the study is to learn whether caregivers are more confident in treating a child's atopic dermatitis after being presented with varying amounts of information.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2018-07-02 |
| Est. Completion | 2018-08-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03559075
The ClinicalTrials.gov registry entry for NCT03559075 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03559075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03559075 about?
NCT03559075 is a clinical study titled "Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis". In dermatology, topical anti-inflammatory medications, such as corticosteroids, are the mainstay treatment of managing patients with atopic dermatitis. However, caregivers are often apprehensive about choosing a topical steroid for a variety of reasons. Many caregivers are not aware that clinical tr...
What is the current status of trial NCT03559075?
This trial is currently completed. The enrollment target is 480 participants. The study started on 2018-07-02. Estimated completion is 2018-08-08.
Who is sponsoring clinical trial NCT03559075?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.